ChemCodes Announces Drug Discovery Agreement With Roche
Oct. 15, 2002 - ChemCodes today announced a research agreement with Roche under which ChemCodes will use its proprietary chemistry platform to discover and optimize synthetic reactions to produce novel lead compounds for an important Roche target.
Financial terms of the agreement were not disclosed.
ChemCodes will engage its medicinal chemistry platform that includes high throughput chemical reactivity mapping, experimental design, experimental tracking, chemo-informatics and data analysis tools.
"We are excited to work with Roche to add value to its drug discovery efforts," said John Didsbury, Ph.D., President and CEO of ChemCodes. "At ChemCodes, we believe that the discovery and application of new chemistries for hit scaffolds will generate novel lead compounds for our partners. Pharmaceutical industry pressures for speed in discovery of new chemical entities, with limited medicinal chemistry resources, have limited the exploration of new synthetic routes needed to achieve desired compound diversity. ChemCodes systematically and comprehensively scans viable chemistries, running thousands of different reaction conditions off of a starting chemical scaffold in a controlled, standardized & parallel approach. All reaction synthesis data is captured in large databases and utilized to enable subsequent chemistries to be carried out more efficiently. This eliminates time consuming rehearsals, gives a greater scope of diversity in lead compounds and allows one to rapidly explore new, and oftentimes more challenging chemistries that may not be typically explored."
"We are pleased to work with ChemCodes and apply their promising and innovative reaction mapping technology to complement our own work on this key project," said Nader Fotouhi, Ph.D., Vice President of Discovery Chemistry of Roche. "We feel that ChemCodes has a strong team and look forward to working with them to advance this important drug discovery program as quickly as possible."
Most read news
Other news from the department science

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Last viewed contents

Insecticides affect aquatic insects in unexpected ways

High-precision magnetic field sensing - Highly sensitive sensor may find widespread use in medicine and other areas
Record quantum entanglement of multiple dimensions - Two Schrödinger cats which could be alive, dead, or in 101 other states simultaneously
